← Open Payments lookup

MARC GARFIELD: Open Payments

NPI 1407899586 · PHILADELPHIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$766 in 34 payments from 15 companies in 2025. Trend: 2023 $67 · 2024 $650 · 2025 $766

Food & beverage: $667Education: $99
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP8$163
Astellas Pharma US Inc4$146
Sumitomo Pharma America, Inc.4$75
Braeburn Inc.3$72
Lilly USA, LLC3$64
KVK-Tech, Inc.1$45
ABBVIE INC.2$36
Amgen Inc.2$35
PFIZER INC.1$27
Aimmune Therapeutics, Inc.1$26

Products named: GEMTESA, BRIXADI, MOUNJARO, AIRSUPRA, Veozah, LOKELMA, BREZTRI, VRAYLAR.

Industry payments across PA — which companies pay providers there.